Peptide Therapeutics Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Application (Gastrointestinal Disorders, Respiratory Disorders, Central Nervous System Disorders, Cancer Disorders, Other Applications); Route of Administration (Parenteral, Oral, Others)

Report Code: TIPRE00018775 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Peptides are the combination of two or more amino acid monomers linked by amide bonds. Researchers has demonstrated that peptide are distinguished from proteins on the basis of size. As a benchmark, molecules with less than 50 amino acids are considered as peptides. Peptides act by binding to specific cell surface receptors and mimics like receptor ligands and help in treatment of diseases by acting on the cell membrane.

MARKET DYNAMICS

The peptide therapeutics drugs market growth is driven by factors such as increasing prevalence of cancer and metabolic disorders such as osteoporosis, obesity, & diabetes. However, stringent regulations is expected to hamper the market growth.

MARKET SCOPE

The "Peptide Therapeutics Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of peptide therapeutics drugs market with detailed market segmentation application, route of administration and region. The peptide therapeutics drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in peptide therapeutics drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The peptide therapeutics drugs market is segmented on the basis of application, route of administration. On the basis of application, the market is segmented into gastrointestinal disorders, respiratory disorders, central nervous system disorders, cancer disorders, other applications. On the basis of route of administration, the market is segmented into parenteral, oral, others.
?

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Peptide Therapeutics Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Peptide Therapeutics Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Peptide Therapeutics Drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Peptide Therapeutics Drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the peptide therapeutics drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from peptide therapeutics drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for peptide therapeutics drugs market in the global market. Below mentioned is the list of few companies engaged in the peptide therapeutics drugs market.

The report also includes the profiles of key players in peptide therapeutics drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Eli Lilly and Company
- Amgen, Inc.
- Pfizer, Inc.
- Bristol-Myers Squibb
- EVER NEURO PHARMA GMBH
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceuticals Industries Ltd
- AstraZeneca PLC
- GlaxoSmithKline plc
- Novo Nordisk A/S.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Peptide Therapeutics Drugs Market - By Application
1.3.2 Peptide Therapeutics Drugs Market - By Route of Administration
1.3.3 Peptide Therapeutics Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PEPTIDE THERAPEUTICS DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. PEPTIDE THERAPEUTICS DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PEPTIDE THERAPEUTICS DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. PEPTIDE THERAPEUTICS DRUGS - GLOBAL MARKET OVERVIEW
6.2. PEPTIDE THERAPEUTICS DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PEPTIDE THERAPEUTICS DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. GASTROINTESTINAL DISORDERS
7.3.1. Overview
7.3.2. Gastrointestinal Disorders Market Forecast and Analysis
7.4. RESPIRATORY DISORDERS
7.4.1. Overview
7.4.2. Respiratory Disorders Market Forecast and Analysis
7.5. CENTRAL NERVOUS SYSTEM DISORDERS
7.5.1. Overview
7.5.2. Central Nervous System Disorders Market Forecast and Analysis
7.6. CANCER DISORDERS
7.6.1. Overview
7.6.2. Cancer Disorders Market Forecast and Analysis
7.7. OTHER APPLICATIONS
7.7.1. Overview
7.7.2. Other Applications Market Forecast and Analysis
8. PEPTIDE THERAPEUTICS DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. PARENTERAL
8.3.1. Overview
8.3.2. Parenteral Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. PEPTIDE THERAPEUTICS DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Peptide Therapeutics Drugs Market Overview
9.1.2 North America Peptide Therapeutics Drugs Market Forecasts and Analysis
9.1.3 North America Peptide Therapeutics Drugs Market Forecasts and Analysis - By Application
9.1.4 North America Peptide Therapeutics Drugs Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Peptide Therapeutics Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Peptide Therapeutics Drugs Market
9.1.5.1.1 United States Peptide Therapeutics Drugs Market by Application
9.1.5.1.2 United States Peptide Therapeutics Drugs Market by Route of Administration
9.1.5.2 Canada Peptide Therapeutics Drugs Market
9.1.5.2.1 Canada Peptide Therapeutics Drugs Market by Application
9.1.5.2.2 Canada Peptide Therapeutics Drugs Market by Route of Administration
9.1.5.3 Mexico Peptide Therapeutics Drugs Market
9.1.5.3.1 Mexico Peptide Therapeutics Drugs Market by Application
9.1.5.3.2 Mexico Peptide Therapeutics Drugs Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Peptide Therapeutics Drugs Market Overview
9.2.2 Europe Peptide Therapeutics Drugs Market Forecasts and Analysis
9.2.3 Europe Peptide Therapeutics Drugs Market Forecasts and Analysis - By Application
9.2.4 Europe Peptide Therapeutics Drugs Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Peptide Therapeutics Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Peptide Therapeutics Drugs Market
9.2.5.1.1 Germany Peptide Therapeutics Drugs Market by Application
9.2.5.1.2 Germany Peptide Therapeutics Drugs Market by Route of Administration
9.2.5.2 France Peptide Therapeutics Drugs Market
9.2.5.2.1 France Peptide Therapeutics Drugs Market by Application
9.2.5.2.2 France Peptide Therapeutics Drugs Market by Route of Administration
9.2.5.3 Italy Peptide Therapeutics Drugs Market
9.2.5.3.1 Italy Peptide Therapeutics Drugs Market by Application
9.2.5.3.2 Italy Peptide Therapeutics Drugs Market by Route of Administration
9.2.5.4 Spain Peptide Therapeutics Drugs Market
9.2.5.4.1 Spain Peptide Therapeutics Drugs Market by Application
9.2.5.4.2 Spain Peptide Therapeutics Drugs Market by Route of Administration
9.2.5.5 United Kingdom Peptide Therapeutics Drugs Market
9.2.5.5.1 United Kingdom Peptide Therapeutics Drugs Market by Application
9.2.5.5.2 United Kingdom Peptide Therapeutics Drugs Market by Route of Administration
9.2.5.6 Rest of Europe Peptide Therapeutics Drugs Market
9.2.5.6.1 Rest of Europe Peptide Therapeutics Drugs Market by Application
9.2.5.6.2 Rest of Europe Peptide Therapeutics Drugs Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Peptide Therapeutics Drugs Market Overview
9.3.2 Asia-Pacific Peptide Therapeutics Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Peptide Therapeutics Drugs Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Peptide Therapeutics Drugs Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Peptide Therapeutics Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Peptide Therapeutics Drugs Market
9.3.5.1.1 Australia Peptide Therapeutics Drugs Market by Application
9.3.5.1.2 Australia Peptide Therapeutics Drugs Market by Route of Administration
9.3.5.2 China Peptide Therapeutics Drugs Market
9.3.5.2.1 China Peptide Therapeutics Drugs Market by Application
9.3.5.2.2 China Peptide Therapeutics Drugs Market by Route of Administration
9.3.5.3 India Peptide Therapeutics Drugs Market
9.3.5.3.1 India Peptide Therapeutics Drugs Market by Application
9.3.5.3.2 India Peptide Therapeutics Drugs Market by Route of Administration
9.3.5.4 Japan Peptide Therapeutics Drugs Market
9.3.5.4.1 Japan Peptide Therapeutics Drugs Market by Application
9.3.5.4.2 Japan Peptide Therapeutics Drugs Market by Route of Administration
9.3.5.5 South Korea Peptide Therapeutics Drugs Market
9.3.5.5.1 South Korea Peptide Therapeutics Drugs Market by Application
9.3.5.5.2 South Korea Peptide Therapeutics Drugs Market by Route of Administration
9.3.5.6 Rest of Asia-Pacific Peptide Therapeutics Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Peptide Therapeutics Drugs Market by Application
9.3.5.6.2 Rest of Asia-Pacific Peptide Therapeutics Drugs Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Peptide Therapeutics Drugs Market Overview
9.4.2 Middle East and Africa Peptide Therapeutics Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Peptide Therapeutics Drugs Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Peptide Therapeutics Drugs Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Peptide Therapeutics Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Peptide Therapeutics Drugs Market
9.4.5.1.1 South Africa Peptide Therapeutics Drugs Market by Application
9.4.5.1.2 South Africa Peptide Therapeutics Drugs Market by Route of Administration
9.4.5.2 Saudi Arabia Peptide Therapeutics Drugs Market
9.4.5.2.1 Saudi Arabia Peptide Therapeutics Drugs Market by Application
9.4.5.2.2 Saudi Arabia Peptide Therapeutics Drugs Market by Route of Administration
9.4.5.3 U.A.E Peptide Therapeutics Drugs Market
9.4.5.3.1 U.A.E Peptide Therapeutics Drugs Market by Application
9.4.5.3.2 U.A.E Peptide Therapeutics Drugs Market by Route of Administration
9.4.5.4 Rest of Middle East and Africa Peptide Therapeutics Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Peptide Therapeutics Drugs Market by Application
9.4.5.4.2 Rest of Middle East and Africa Peptide Therapeutics Drugs Market by Route of Administration
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PEPTIDE THERAPEUTICS DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PEPTIDE THERAPEUTICS DRUGS MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AMGEN, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOLMYERS SQUIBB
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. EVER NEURO PHARMA GMBH
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TEVA PHARMACEUTICALS INDUSTRIES LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ASTRAZENECA PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GLAXOSMITHKLINE PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NOVO NORDISK AS.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Eli Lilly and Company
2. Amgen, Inc.
3. Pfizer, Inc.
4. Bristol-Myers Squibb
5. EVER NEURO PHARMA GMBH
6. Takeda Pharmaceutical Company Limited
7. Teva Pharmaceuticals Industries Ltd
8. AstraZeneca PLC
9. GlaxoSmithKline plc
10. Novo Nordisk A/S.

TIPRE00018775
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking